Trial Profile
Dasatinib in patients with cancer; incidence of pleural effusions
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Aug 2015
Price :
$35
*
At a glance
- Drugs Dasatinib (Primary)
- Indications Haematological malignancies; Solid tumours
- Focus Adverse reactions
- 18 Aug 2015 New trial record